Immunotherapy

Cancer immunotherapy (sometimes called immuno-oncology) is the stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight the disease.

Read more in the app

AI analysis of PET/CT images can predict side effects of immunotherapy in lung cancer - EurekAlert

Researchers find metabolic mechanism that blocks immune response, immunotherapy in cancer - EurekAlert

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer - EurekAlert

Immunotherapy boosts survival of advanced Hodgkin lymphoma

92% Survival Rate: Immunotherapy Boosts Survival of Advanced Hodgkin Lymphoma

Immune signatures may predict adverse events from immunotherapy

Disrupting Asxl1 gene prevents T-cell exhaustion, improving immunotherapy

An epigenetic characteristic help predict efficacy of immunotherapy in multiple myeloma - EurekAlert

Immunotherapy for gum disease? Study in mice shows promise

Immunotherapy for gum disease? Study in mice shows promise - EurekAlert

Combination treatment improves response to immunotherapy for lung cancer

Long-term metastatic melanoma survival dramatically improves on immunotherapy, study finds

Immunotherapy shows promise for men with specific types of prostate cancer

Long-term metastatic melanoma survival dramatically improves on immunotherapy - EurekAlert

Five key factors predict the response of cancer patients to immunotherapy

Immunotherapy before and after lung cancer surgery reduces death risk, disease recurrence - EurekAlert

Gut bacteria influence responses to immunotherapy in patients with asbestos related cancer

Gut bacteria influence responses to immunotherapy in patients with asbestos related cancer, Leicester study finds - EurekAlert

Drug bypasses suppressive immune cells to unleash immunotherapy

Blood test may guide use of multiple myeloma immunotherapy